INS and metabolic dysfunction-associated steatotic liver disease: The metabolic markers found to best illustrate NAFLD are: high BMI and abdominal fat, insulin resistance, and increased blood insulin, HbA1c, triglycerides, transaminases, GT, ferritin, creatinine, and uric acid levels, in contrast to a reduction in serum HDL cholesterol.